“High–dose” calcitriol for control of renal osteodystrophy in children on CAPD

This publication has 24 references indexed in Scilit:

• Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis
  New England Journal of Medicine, 1986
• Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis
  The Journal of Pediatrics, 1986
• Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide.
  BMJ, 1985
• Role of aluminum hydroxide in raising serum aluminum levels in children undergoing continuous ambulatory peritoneal dialysis
  The Journal of Pediatrics, 1984
• Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis
  The Journal of Pediatrics, 1983
• Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis
  Kidney International, 1983
• 25-Hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: Beneficial effect on linear growth velocity
  The Journal of Pediatrics, 1982
• Increased Growth after Long-Term Oral 1α,25-Vitamin D₃in Childhood Renal Osteodystrophy
  New England Journal of Medicine, 1978
• Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure
  Kidney International, 1976
• Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease.
  Journal of Clinical Investigation, 1975